Tricida (TCDA) Announces $42M Direct Financing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/17/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. PNC
10. NEST:IN

Go back to Tricida (TCDA) Announces $42M Direct Financing

Tricida Raises $42 Million in Registered Direct Equity Financing

November 15, 2021 7:30 AM EST

SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer, a non-absorbed, orally-administered polymer designed to slow chronic kidney disease (CKD) progression in patients with metabolic acidosis and CKD, announced today that it has entered into definitive agreements with certain investors for the purchase and sale of common stock, pre-funded warrants and common warrants in a registered direct equity financing (the Financing) for gross proceeds to Tricida of approximately $42 million. Deep Track Capital is leading the Financing,... More